Shandong Linuo Pharmaceutical Packaging Co., Ltd. (SHE:301188)

China · Delayed Price · Currency is CNY

33.19

+1.57 (4.97%)

Jul 31, 2026, 3:04 PM CST

SHE:301188 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	1,026	981.47	1,081	947.37	822.02	888.88
Revenue Growth	-5.90%	-9.19%	14.09%	15.25%	-7.52%	34.67%
Gross Profit	211.83	198.88	195.95	159.64	175.47	218.46
Operating Income	60.45	53.58	72.59	56.96	93.99	127.51
Net Income	40.14	39.66	66.07	65.92	116.65	124.78
Earnings Per Share	0.17	0.17	0.29	0.28	0.50	0.70
EPS Growth	-51.54%	-41.38%	3.57%	-44.00%	-28.57%	34.62%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	738.56
Overseas	242.91
Total	981.47

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	544.48	577.88	786.24	899.78	530.88	710.79
Total Debt	292.83	627.34	411.13	372.29	1.04	26.53
Net Cash (Debt)	251.65	-49.46	375.11	527.49	529.84	684.26
Net Cash Growth	-26.55%	-	-28.89%	-0.44%	-22.57%	2882.97%
Net Cash Per Share	1.08	-0.21	1.65	2.24	2.27	3.84

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	-17.92	-19.33	123.01	61.39	46.39	52.47
Capital Expenditures	-300.15	-287.17	-209.56	-113.43	-162.37	-73.38
Free Cash Flow	-318.07	-306.5	-86.55	-52.04	-115.99	-20.91
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	20.66%	20.26%	18.13%	16.85%	21.35%	24.58%
Operating Margin	5.89%	5.46%	6.72%	6.01%	11.43%	14.34%
Pretax Margin	5.35%	5.01%	6.61%	7.69%	15.42%	15.78%
Profit Margin	3.91%	4.04%	6.11%	6.96%	14.19%	14.04%
FCF Margin	-31.01%	-31.23%	-8.01%	-5.49%	-14.11%	-2.35%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Dividend Per Share	0.100	0.100	0.100	0.100	0.200	0.200
Dividend Per Share Growth	0%	0%	0%	-50.00%	0%	-
Dividend Yield	0.30%	0.57%	0.67%	0.57%	1.50%	0.84%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	193.49	103.24	52.05	63.08	27.14	45.82
Forward PE	85.10	29.25	20.47	34.57	20.79	-
PS Ratio	8.40	4.17	3.18	4.39	3.85	6.43